FILING ANALYSIS · WEDNESDAY, NOVEMBER 4
LIFECORE BIOMEDICAL, INC. \DE\ LFCR — 8-K: Results of Operations and Financial Condition
negative
Lifecore Biomedical reported a net loss of $40.1 million or $1.08 loss per diluted share for the third quarter, with revenues decreasing 18.6% year-over-year to $25.3 million, and the company's liquidity position includes $38.0 million, with cash of $23.0 million and revolving credit availability of $15.0 million. The results show a significant decline in revenue and gross profit compared to the p
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →